Indefinite Delivery Contract 36C25626D0014
Award Date 10/15/25
Last Date to Order 9/30/30
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs on November 1, 2025. The contract, valued at $500,000 ceiling with a guaranteed minimum of $1,000, extends through October 31, 2030, and provides chemotherapy preparation and compounding services for the Amarillo VA Medical Center in...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 17 (VISN 17) on November 1, 2025, to provide pharmacy compounding services for oncology drugs at the Dallas Veterans Affairs Healthcare System. The contract has a ceiling value of $6,000,000 and extends through October 31, 2030. The prime contractor will deliver chemotherapy preparation services to the North Texas VA...
- This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $2,012,758.65 single-award contract, which has a period of performance ending on September 30, 2026, is for the provision of compounded chemotherapy and other specialized pharmaceutical services primarily to support the VA's Veterans Health Administration. The contract originated from an unrestricted/full and open...
- This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award contract, valued at up to $800,000, is for pharmacy compounding services to support VA oncology and infusion treatment programs nationwide. Optum Pharmacy, a 503A certified pharmacy, will provide specialized pharmaceutical compounding services including the preparation of customized chemotherapy agents, hazardous...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
- The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, is for the provision of specialized pharmacy compounding services to support the Veterans Integrated Service Network 16 (VISN 16) in the Gulf Coast region. Under this single-award $4.5M Indefinite Delivery Contract, which has a period of performance through September 2024, Optum Pharmacy 601 will deliver a range of customized pharmaceutical...
- This indefinite delivery contract was awarded by the Veterans Integrated Service Network 2, a civilian federal agency, to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $1,071,930.52 and a period of performance from October 1, 2025 to September 30, 2026. The contract is for chemo compounding services, with a single task order for $1,071,930.52 to provide these services. The place of performance is Chandler, Arizona. No...
- This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $1,500,000, is for emergency compounding services to support the VA's Veterans Integrated Service Network (VISN) 16 in the New Orleans, Louisiana area. The contract has a period of performance from September 2021 through September 2025. Under this IDC, Optum...
- This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) and Veterans Health Administration (VHA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $416,900.00 and a period of performance through November 19, 2025. Optum Pharmacy 601 is providing chemotherapy compound drug hood services to support veterans' healthcare programs, particularly through the VA's Veterans Integrated Service Networks...